+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

From
From
From
TIGIT Inhibitors - Competitive Landscape, 2026 - Product Thumbnail Image

TIGIT Inhibitors - Competitive Landscape, 2026

  • Report
  • January 2026
  • 100 Pages
  • Global
From
Oncolytic Virus - Competitive Landscape, 2026 - Product Thumbnail Image

Oncolytic Virus - Competitive Landscape, 2026

  • Report
  • January 2026
  • 250 Pages
  • Global
From
From
From
From
From
From
STAT Inhibitors - Pipeline Insight, 2026 - Product Thumbnail Image

STAT Inhibitors - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 180 Pages
  • Global
From
Acute Lymphocytic Leukemia (ALL) - Pipeline Insight, 2026 - Product Thumbnail Image

Acute Lymphocytic Leukemia (ALL) - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 280 Pages
  • Global
From
From
Pancreatic Cancer - Pipeline Insight, 2026 - Product Thumbnail Image

Pancreatic Cancer - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 450 Pages
  • Global
From
Medullary Thyroid Cancer - Pipeline Insight, 2026 - Product Thumbnail Image

Medullary Thyroid Cancer - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 60 Pages
  • Global
From
Myelofibrosis - Pipeline Insight, 2026 - Product Thumbnail Image

Myelofibrosis - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 180 Pages
  • Global
From
HEPZATO-KIT Sales Forecast and Market Size Analysis - 2034 - Product Thumbnail Image

HEPZATO-KIT Sales Forecast and Market Size Analysis - 2034

  • Report
  • April 2026
  • 30 Pages
  • Global
From
Darovasertib Sales Forecast and Market Size Analysis - 2034 - Product Thumbnail Image

Darovasertib Sales Forecast and Market Size Analysis - 2034

  • Report
  • April 2026
  • 30 Pages
  • Global
From
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more